Geriatric drug labeling

FDA is soliciting public comment on its proposed collection of information on the “Geriatric Use” subsection of labeling for prescription drugs. Information related to the use of the drug by elderly or geriatric patients must be included, where appropriate, in the precautions, indications and usage, dosage and administration, clinical pharmacology or clinical studies, contraindications, and warnings sections.